Sanofi Draws Fire Over Cost of MS Drug Lemtrada

Sanofi draws fire over cost of MS drug Lemtrada

Filed under: drug treatment news 2012

The injectable drug, chemically known as alemtuzumab, was sold until September 2012 under the name Campath as treatment for leukemia and given more frequently at a higher dosage. "There is concern that with a license for multiple sclerosis, the cost of …
Read more on Reuters

New drug significantly lowers bad cholesterol

Filed under: drug treatment news 2012

Now researchers at Brigham and Women's Hospital have shown that in patients already on a statin, the addition of a new drug, called AMG 145, can reduce LDL cholesterol levels by up to 66 percent after 12 weeks. The study was presented at the 2012 …
Read more on Medical Xpress

PropThink: Biogen Idec: rFVIIIFc Trials Somewhat Disappointing, but ALS Trials …

Filed under: drug treatment news 2012

It has already been granted priority review, and when compared with the existing treatment options for ALS, there is little reason to deny approval. In reviewing a company's NDA or BLA, the FDA takes into account the marginal benefits of a drug, asking …
Read more on Reuters

5 Biotech Stocks Poised For Upside Gains

Filed under: drug treatment news 2012

8, 2012, the company announced additional preliminary results from an open-label Phase 2 drug-drug interaction study (Study 013) to evaluate a single oral dose of migalastat HCl (150 mg or 450 mg) co-administered with enzyme replacement therapy (ERT) …
Read more on Reuters